Lefevre,Mate that is not the case. He didnt buy the options on...

Lefevre,

Mate that is not the case. He didnt buy the options on market on the 3rd of July. Refer to change of director interest announced 7th of May. He held the options at this point. All he did on Wednesday was convert the options to fully paid shares.

This keeps the floor open for ANP to announce whatever they want, whenever they want to.

What also gets me excited, is the last major runup in Novemeber 2011 when the stock put on 400% running from 0.9 to 3.9cents, was without news, and every Asx Query into the move resulted in the company saying it was due to "expectations of ATL1103 results". Well here we have expectations of ATL1103 entering into licensing with an international pharmaceutical company. ATL1103 has so much potential, and given the history of ANP to run like the wind, and the recent spate of directors buying on market @ 1.7cents 1.8cents, I personally even as a trader, cant bring myself to take a measily 3 pips (average 1.75cent buy in price) given the storm that is brewing.

The only thing that might limit this move, is the options expiring, but what that means is that here we have a cashed up company, with 3 irons in the fire, who wont have to raise capital any time soon. In otherwords this is the last of the dilution, no more shares after these, so value per share can be accounted for, and ANP can do what we all want it to do.

Happy to holding.